Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204) Meeting Abstract
| Authors: | Tawbi, H. A. H.; Forsyth, P. A. J.; Hodi, F. S.; Lao, C. D.; Moschos, S. J.; Hamid, O.; Atkins, M. B.; Lewis, K. D.; Thomas, R. P.; Glaspy, J. A.; Jang, S.; Algazi, A. P.; Khushalani, N. I.; Postow, M. A.; Pavlick, A. C.; Ernstoff, M. S.; Reardon, D. A.; Balogh, A.; Rizzo, J. I.; Margolin, K. A. |
| Abstract Title: | Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 508s |
| Language: | English |
| ACCESSION: | WOS:000487345806555 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.9501 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9501 -- Source: Wos |
